News / Taiwan / cnyes
Center Lab August Revenue Rises 61.5% YoY
Health Technology · Pharmaceuticals: Major · cnyes · 2026-09-08
4123
Biotech firm Center Lab (4123) reported August 2026 revenue of NT$151 million, a 61.53% year-over-year increase, with cumulative growth at 22.2%.
What Happened
Revenue Results: Center Lab (4123) announced August 2026 revenue of NT$151 million, marking a strong year-over-year growth of 61.53%, while the monthly growth rate was -3.56%.
Cumulative Performance: For the first eight months of 2026, the company achieved a cumulative revenue of NT$1.206 billion, representing a year-to-date growth of 22.2%.
Stock Movement: The stock is currently priced at NT$30.4, with a 3.52% decline over the past five trading days, reflecting the broader downward trend of the biotech sector index, which fell by 0.91%.
Business Profile: Center Lab operates in the biotechnology and healthcare industry, focusing on the manufacturing, wholesale, and retail of pharmaceutical products.